OA11086A - Process for preparing eprosartan - Google Patents

Process for preparing eprosartan Download PDF

Info

Publication number
OA11086A
OA11086A OA9900180A OA9900180A OA11086A OA 11086 A OA11086 A OA 11086A OA 9900180 A OA9900180 A OA 9900180A OA 9900180 A OA9900180 A OA 9900180A OA 11086 A OA11086 A OA 11086A
Authority
OA
OAPI
Prior art keywords
compound
formula
process according
butyl
sait
Prior art date
Application number
OA9900180A
Other languages
English (en)
Inventor
Richard T Matsuoka
Peng Liu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of OA11086A publication Critical patent/OA11086A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
OA9900180A 1997-02-14 1999-08-13 Process for preparing eprosartan OA11086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14

Publications (1)

Publication Number Publication Date
OA11086A true OA11086A (en) 2003-03-13

Family

ID=21898590

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900180A OA11086A (en) 1997-02-14 1999-08-13 Process for preparing eprosartan

Country Status (41)

Country Link
US (2) US6294675B1 (xx)
EP (1) EP0973769B1 (xx)
JP (1) JP4227671B2 (xx)
KR (1) KR100551667B1 (xx)
CN (1) CN1093128C (xx)
AP (1) AP1202A (xx)
AR (1) AR011126A1 (xx)
AT (1) ATE274511T1 (xx)
AU (1) AU730162B2 (xx)
BG (1) BG63970B1 (xx)
BR (1) BRPI9808642B8 (xx)
CA (1) CA2281471C (xx)
CO (1) CO4950549A1 (xx)
CY (1) CY2551B1 (xx)
CZ (1) CZ296543B6 (xx)
DE (1) DE69825880T2 (xx)
DK (1) DK0973769T3 (xx)
DZ (1) DZ2418A1 (xx)
EA (1) EA001761B1 (xx)
EG (1) EG23780A (xx)
ES (1) ES2224358T3 (xx)
HK (1) HK1026206A1 (xx)
HU (1) HU228098B1 (xx)
ID (1) ID23155A (xx)
IL (4) IL143784A (xx)
IN (1) IN188000B (xx)
MA (1) MA24472A1 (xx)
MY (1) MY120024A (xx)
NO (1) NO317761B1 (xx)
NZ (1) NZ337182A (xx)
OA (1) OA11086A (xx)
PE (1) PE59799A1 (xx)
PL (1) PL192837B1 (xx)
PT (1) PT973769E (xx)
SA (1) SA98190146B1 (xx)
SI (1) SI0973769T1 (xx)
SK (1) SK285125B6 (xx)
TR (1) TR199901935T2 (xx)
UA (1) UA57060C2 (xx)
WO (1) WO1998035962A1 (xx)
ZA (1) ZA981208B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
JP4575594B2 (ja) * 1998-07-20 2010-11-04 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 経口用固体剤形のエプロサルタン配合の生体内強化性処方
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
EP2097408A4 (en) * 2006-12-27 2010-08-25 Hetero Drugs Ltd IMPROVED PROCESS FOR THE PREPARATION OF EPROSARTAN
CA2703231A1 (en) * 2007-10-22 2009-04-30 Orchid Research Laboratories Limited Histone deacetylase inhibitors
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
DK0955294T3 (da) 1989-06-14 2004-02-02 Smithkline Beecham Corp Imidazolylalkensyre
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
DE69133019T2 (de) * 1990-12-14 2002-11-28 Smithkline Beecham Corp Imidazolyl-alkencarbonsäuren
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
SK285125B6 (sk) 2006-06-01
CA2281471C (en) 2007-04-24
BR9808642B1 (pt) 2013-11-26
CZ296543B6 (cs) 2006-04-12
EP0973769A4 (en) 2001-01-24
HK1026206A1 (en) 2000-12-08
JP4227671B2 (ja) 2009-02-18
PE59799A1 (es) 1999-08-06
EP0973769A1 (en) 2000-01-26
CO4950549A1 (es) 2000-09-01
BG103649A (en) 2000-06-30
US6458963B1 (en) 2002-10-01
KR20000071008A (ko) 2000-11-25
HU228098B1 (en) 2012-10-29
JP2001511808A (ja) 2001-08-14
ID23155A (id) 2000-03-23
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
HUP0001813A3 (en) 2001-07-30
AP9901619A0 (en) 1999-09-30
UA57060C2 (uk) 2003-06-16
IN188000B (xx) 2002-08-03
CN1247538A (zh) 2000-03-15
DE69825880D1 (de) 2004-09-30
DE69825880T2 (de) 2005-09-08
IL143783A (en) 2005-05-17
IL143784A (en) 2005-05-17
PL335074A1 (en) 2000-04-10
NZ337182A (en) 2001-04-27
NO317761B1 (no) 2004-12-13
KR100551667B1 (ko) 2006-02-13
WO1998035962A1 (en) 1998-08-20
NO993912D0 (no) 1999-08-13
EA001761B1 (ru) 2001-08-27
SI0973769T1 (en) 2004-12-31
CA2281471A1 (en) 1998-08-20
AU6273298A (en) 1998-09-08
IL131310A (en) 2003-02-12
DZ2418A1 (fr) 2003-06-26
BRPI9808642B8 (pt) 2021-05-25
CY2551B1 (en) 2008-07-02
AU730162B2 (en) 2001-03-01
CN1093128C (zh) 2002-10-23
IL143785A0 (en) 2002-04-21
SK108699A3 (en) 2000-05-16
ZA981208B (en) 1998-11-12
AR011126A1 (es) 2000-08-02
IL143784A0 (en) 2002-04-21
PL192837B1 (pl) 2006-12-29
HUP0001813A2 (hu) 2001-06-28
EA199900741A1 (ru) 2000-02-28
ES2224358T3 (es) 2005-03-01
TR199901935T2 (xx) 1999-12-21
IL143783A0 (en) 2002-04-21
EP0973769B1 (en) 2004-08-25
BG63970B1 (bg) 2003-08-29
DK0973769T3 (da) 2004-12-13
EG23780A (en) 2007-08-13
US20020028951A1 (en) 2002-03-07
BR9808642A (pt) 2000-05-23
NO993912L (no) 1999-08-13
IL131310A0 (en) 2001-01-28
US6294675B1 (en) 2001-09-25
ATE274511T1 (de) 2004-09-15
IL143785A (en) 2004-12-15
AP1202A (en) 2003-09-02
SA98190146B1 (ar) 2006-08-20
CZ285199A3 (cs) 2000-02-16
MA24472A1 (fr) 1998-10-01

Similar Documents

Publication Publication Date Title
OA11086A (en) Process for preparing eprosartan
JP6300277B2 (ja) （５−フルオロ−２−メチル−３−キノリン−２−イルメチル−インドール−１−イル）−酢酸エステルの製造のための方法
US6172237B1 (en) Process for preparing eprosartan
EP0634409B1 (en) Process of producing 2-cyano-4-oxo-4H-benzopyran compounds
EP1484321B1 (en) Process for preparing 1-methylindazole-3-carboxylic acid
MXPA99007533A (en) Process for preparing eprosartan
JP3257779B2 (ja) タートラニル酸類の製造法
KR100377695B1 (ko) 히드록삼산의 제조방법
WO2022208545A1 (en) Hydrogenation of imines by palladium based catalyst
US6316633B1 (en) Process for manufacture of chiral succinic acid derivatives
CN117903131A (zh) 一种非奈利酮的改进合成方法
MXPA98008000A (en) Process for preparing succinic acid derivatives qui
JPH07138216A (ja) Ｎ−ｔ−ブトキシメチル（メタ）アクリルアミドの製造方法
JP2002518376A (ja) ホルミルイミダゾールの製造方法
JP2001523668A (ja) ホルミルイミダゾールの製法
EP0781775A2 (en) Process for producing 1-hydroxythienoimidazole carboxylic acid and thienoimidazole carboxylic acid